Abstract
The present disclosure relates to method of obtaining high purity glucans, in particular yeast glucans with immunomodulatory properties, including vaccine adjuvant properties for the use as adjuvant in vaccines.
| Original language | English |
|---|---|
| Patent number | EP4291241A1 |
| IPC | A61K47/36,C08B37/00,C12P19/04 |
| Priority date | 14/02/21 |
| Filing date | 11/02/23 |
| Publication status | Submitted - 11 Feb 2023 |